Viewing Study NCT06556368


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2025-12-24 @ 5:45 PM
Study NCT ID: NCT06556368
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2024-08-12
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
Sponsor: Kodiak Sciences Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-23
Start Date Type: ACTUAL
Primary Completion Date: 2026-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-08
Completion Date Type: ESTIMATED
First Submit Date: 2024-08-12
First Submit QC Date: None
Study First Post Date: 2024-08-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-23
Last Update Post Date: 2025-10-27
Last Update Post Date Type: ESTIMATED